AI Pickup
U.S. Stock Market Prediction U.S. Stock Forecast Tomorrow World Stock Markets ETF Market Prediction ETF Forecast Tomorrow Cryptocurrency Prediction Forex Market Prediction Currency Conversion Sign In Sign Up
menu
Go:
Wall street
Forecast
AI Pickup
U.S. Stock Market Prediction U.S. Stock Forecast Tomorrow World Stock Markets
Featured and All ETFs ETF Forecast Tomorrow
Featured and All Cryptocurrencies
Forex Market Prediction Currency Conversion
Sign In
Sign Up
Go to >>
By Wall Street
Price forecast
Financial Info
























































































































    You are here:
  • Home
  • USA stock market prediction
  • TPTX stock forecast
Statistics of AI Pickup
See New Opinions/Signals for ALL Tickers
Statistics from all past Buy/Sell opinions in AI Pickup
Total return : 3178.18 %
Number of direction forecasts : 3810

Click to see the forecast history of all tickers

TPTX : Turning Point Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis

year Average Low High Change from close on 2022-07-06
2022 $72.3 $69.84 $75.05 -3.83%
2023 $68.79 $68.49 $69.24 -8.5%
2024 $68.91 $63.33 $71.44 -8.34%
2025 $57.74 $49.16 $63.64 -23.2%
2026 $43.49 $40.46 $48.04 -42.16%
2027 $38.96 $37.96 $40.17 -48.18%
2028 $37.21 $36.73 $37.82 -50.51%
2029 $36.46 $36.3 $36.67 -51.5%
2030 $36.2 $36.1 $36.28 -51.85%
2031 $35.76 $35.34 $36.07 -52.44%
2032 $35.14 $35.08 $35.27 -53.26%

The 8 Wall Street analysts offering Turning Point Therapeutics stock forecast in the last 6 months have average price target of $88.63 with a high forecast of $161.0 and a low forecast of $45.0. The average Turning Point Therapeutics stock forecast represents a 17.89% increase from the last price of $75.1800003051758.

From AI system, total return is 3178.18% from 3810 forecasts. For Turning Point Therapeutics stock forecast for 2022, 5 predictions are offered for each month of 2022 with average Turning Point Therapeutics stock forecast of $72.3, a high forecast of $75.05, and a low forecast of $69.84. The average Turning Point Therapeutics stock forecast 2022 represents a -3.83% decrease from the last price of $75.1800003051758.

For Turning Point Therapeutics stock forecast for 2023, 12 predictions are offered for each month of 2023 with average Turning Point Therapeutics stock forecast of $68.79, a high forecast of $69.24, and a low forecast of $68.49. The average Turning Point Therapeutics stock forecast 2023 represents a -8.5% decrease from the last price of $75.1800003051758.

For Turning Point Therapeutics stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Turning Point Therapeutics stock forecast of $57.74, a high forecast of $63.64, and a low forecast of $49.16. The average Turning Point Therapeutics stock forecast 2025 represents a -23.2% decrease from the last price of $75.1800003051758.

For Turning Point Therapeutics stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average Turning Point Therapeutics stock forecast of $38.96, a high forecast of $40.17, and a low forecast of $37.96. The average Turning Point Therapeutics stock forecast 2027 represents a -48.18% decrease from the last price of $75.1800003051758.

For Turning Point Therapeutics stock forecast for 2030, 12 predictions are offered for each month of 2030 with average Turning Point Therapeutics stock forecast of $36.2, a high forecast of $36.28, and a low forecast of $36.1. The average Turning Point Therapeutics stock forecast 2030 represents a -51.85% decrease from the last price of $75.1800003051758.

For Turning Point Therapeutics stock forecast for 2032 (10 year), 7 predictions are offered for each month of 2032 with average Turning Point Therapeutics stock forecast of $35.14, a high forecast of $35.27, and a low forecast of $35.08. The average Turning Point Therapeutics stock forecast 2032 represents a -53.26% decrease from the last price of $75.1800003051758. Please, see more forecasts below.


Table of contents

  • Price target by Wall Street
  • Turning Point Therapeutics stock forecast for upcoming days
  • Long term Turning Point Therapeutics stock forecast
  • Financial Info
  • Frequently Asked Questions (FAQ)
  • 14 Days Historical Data

TPTX : Turning Point Therapeutics stock forecast by Wall Street Analysts

The average Turning Point Therapeutics stock forecast from last 6 month is $88.63, and this show a -17.07% decrease in average from the prior price target of the each prediction. Also, this average forecast of $88.63 represents a -18.24% decrease from the past average forecast of $108.4, 6 months ago from 5 wall street analysts.

Date
Firm
current price target
previous price target
current rating
2022-06-13
SVB Leerink
$76.0000
$101.0000
Market Perform
2022-06-06
Cowen & Co.
Market Perform
2022-06-06
HC Wainwright & Co.
$76.0000
$161.0000
Neutral
2022-06-03
Wedbush
$76.0000
$61.0000
Neutral
2022-05-24
Goldman Sachs
$116.0000
$143.0000
Buy
2022-05-20
B of A Securities
$58.0000
Buy
2022-05-11
SVB Leerink
$101.0000
$107.0000
Outperform
2022-03-22
HC Wainwright & Co.
$161.0000
$162.0000
Buy
2022-03-01
Stifel
$45.0000
$50.0000
Hold
2022-02-10
Wells Fargo
$85.0000
$120.0000
Overweight
2022-01-21
Oppenheimer
$105.0000
$115.0000
Outperform
2021-12-07
Cowen & Co.
Outperform
2021-11-10
Oppenheimer
$115.0000
$150.0000
Outperform
2021-10-12
HC Wainwright & Co.
$162.0000
$178.0000
Buy
2021-10-11
JMP Securities
Market Perform
2021-09-30
Stifel
$75.0000
Hold


Turning Point Therapeutics stock forecast for upcoming days



Date Price Target Change
2022-07-07 $73.40 -2.37%
2022-07-08 $71.64 -2.39%
2022-07-11 $70.98 -0.92%
2022-07-12 $70.77 -0.30%
2022-07-13 $70.12 -0.92%


TPTX : Long term Turning Point Therapeutics stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)

Forecast for 2022 Aug. is $75.05 , for 2023 Jul. is $68.60 , for 2026 Jul. is $42.62 , for 2027 Jul. is $38.80 , for 2031 Jul. is $35.76 , and for 2032 Jul. is $35.08.

TPTX : Turning Point Therapeutics stock forecast for 2022

Date Price Target Change
2022 Aug. $75.05 -0.17%
2022 Sep. $73.73 -1.76%
2022 Oct. $72.11 -2.20%
2022 Nov. $70.78 -1.84%
2022 Dec. $69.84 -1.32%

TPTX : Turning Point Therapeutics stock forecast for 2023

Date Price Target Change
2023 Jan. $69.24 -0.86%
2023 Feb. $68.86 -0.55%
2023 Mar. $68.63 -0.33%
2023 Apr. $68.51 -0.17%
2023 May. $68.49 -0.04%
2023 Jun. $68.53 0.06%
2023 Jul. $68.60 0.11%
2023 Aug. $68.68 0.12%
2023 Sep. $68.81 0.19%
2023 Oct. $68.93 0.17%
2023 Nov. $69.03 0.15%
2023 Dec. $69.17 0.20%

TPTX : Turning Point Therapeutics stock forecast for 2024

Date Price Target Change
2024 Jan. $69.33 0.24%
2024 Feb. $69.51 0.26%
2024 Mar. $69.79 0.40%
2024 Apr. $70.26 0.68%
2024 May. $71.44 1.67%
2024 Jun. $71.07 -0.51%
2024 Jul. $70.71 -0.50%
2024 Aug. $70.12 -0.83%
2024 Sep. $68.99 -1.61%
2024 Oct. $67.17 -2.64%
2024 Nov. $65.22 -2.90%
2024 Dec. $63.33 -2.89%

TPTX : Turning Point Therapeutics stock forecast for 2025

Date Price Target Change
2025 Jan. $62.33 -1.58%
2025 Feb. $63.64 2.10%
2025 Mar. $63.47 -0.27%
2025 Apr. $62.55 -1.45%
2025 May. $61.07 -2.37%
2025 Jun. $59.26 -2.96%
2025 Jul. $57.51 -2.96%
2025 Aug. $56.25 -2.18%
2025 Sep. $55.07 -2.10%
2025 Oct. $52.12 -5.35%
2025 Nov. $50.41 -3.29%
2025 Dec. $49.16 -2.48%

TPTX : Turning Point Therapeutics stock forecast for 2026

Date Price Target Change
2026 Jan. $48.04 -2.28%
2026 Feb. $47.10 -1.95%
2026 Mar. $45.91 -2.54%
2026 Apr. $44.89 -2.21%
2026 May. $44.01 -1.95%
2026 Jun. $43.26 -1.71%
2026 Jul. $42.62 -1.48%
2026 Aug. $42.06 -1.30%
2026 Sep. $41.57 -1.17%
2026 Oct. $41.13 -1.06%
2026 Nov. $40.78 -0.86%
2026 Dec. $40.46 -0.77%

TPTX : Turning Point Therapeutics stock forecast for 2027

Date Price Target Change
2027 Jan. $40.17 -0.72%
2027 Feb. $39.90 -0.68%
2027 Mar. $39.64 -0.65%
2027 Apr. $39.40 -0.59%
2027 May. $39.19 -0.54%
2027 Jun. $38.99 -0.51%
2027 Jul. $38.80 -0.49%
2027 Aug. $38.62 -0.47%
2027 Sep. $38.44 -0.45%
2027 Oct. $38.28 -0.44%
2027 Nov. $38.12 -0.42%
2027 Dec. $37.96 -0.40%

TPTX : Turning Point Therapeutics stock forecast for 2028

Date Price Target Change
2028 Jan. $37.82 -0.38%
2028 Feb. $37.68 -0.36%
2028 Mar. $37.55 -0.34%
2028 Apr. $37.43 -0.32%
2028 May. $37.32 -0.30%
2028 Jun. $37.21 -0.28%
2028 Jul. $37.12 -0.26%
2028 Aug. $37.03 -0.24%
2028 Sep. $36.94 -0.23%
2028 Oct. $36.87 -0.21%
2028 Nov. $36.80 -0.19%
2028 Dec. $36.73 -0.17%

TPTX : Turning Point Therapeutics stock forecast for 2029

Date Price Target Change
2029 Jan. $36.67 -0.16%
2029 Feb. $36.62 -0.14%
2029 Mar. $36.57 -0.13%
2029 Apr. $36.53 -0.12%
2029 May. $36.49 -0.10%
2029 Jun. $36.46 -0.10%
2029 Jul. $36.43 -0.09%
2029 Aug. $36.40 -0.08%
2029 Sep. $36.37 -0.07%
2029 Oct. $36.35 -0.07%
2029 Nov. $36.32 -0.06%
2029 Dec. $36.30 -0.06%

TPTX : Turning Point Therapeutics stock forecast for 2030

Date Price Target Change
2030 Jan. $36.28 -0.05%
2030 Feb. $36.27 -0.05%
2030 Mar. $36.25 -0.05%
2030 Apr. $36.24 -0.04%
2030 May. $36.22 -0.04%
2030 Jun. $36.21 -0.04%
2030 Jul. $36.19 -0.04%
2030 Aug. $36.18 -0.04%
2030 Sep. $36.16 -0.04%
2030 Oct. $36.14 -0.05%
2030 Nov. $36.12 -0.06%
2030 Dec. $36.10 -0.07%

TPTX : Turning Point Therapeutics stock forecast for 2031

Date Price Target Change
2031 Jan. $36.07 -0.08%
2031 Feb. $36.04 -0.09%
2031 Mar. $36.00 -0.11%
2031 Apr. $35.95 -0.13%
2031 May. $35.89 -0.15%
2031 Jun. $35.83 -0.18%
2031 Jul. $35.76 -0.20%
2031 Aug. $35.68 -0.22%
2031 Sep. $35.60 -0.24%
2031 Oct. $35.51 -0.24%
2031 Nov. $35.43 -0.24%
2031 Dec. $35.34 -0.23%

TPTX : Turning Point Therapeutics stock forecast for 2032

Date Price Target Change
2032 Jan. $35.27 -0.21%
2032 Feb. $35.21 -0.18%
2032 Mar. $35.15 -0.15%
2032 Apr. $35.12 -0.11%
2032 May. $35.09 -0.07%
2032 Jun. $35.08 -0.03%
2032 Jul. $35.08 -0.00%


Financial Data for Turning Point Therapeutics stock

Market Cap
3735363328
Held Percent By Insiders
0.737%
Held Percent By Institutions
101.73700000000001%
Sector
Healthcare
Website
https://www.tptherapeutics.com
currency
USD

Forward PE
-10.427184
Enterprise Value
2.81993216E9
Enterprise To Ebitda
-10.668
Enterprise To Revenue
465.873

Average 10 day Volume
1458770
Average Volume
1886935
Fifty Two Week High
$82.2
Fifty Two Week Low
$23.77


Frequently Asked Questions about Turning Point Therapeutics stock forecast

Is Turning Point Therapeutics a good long term stock?

From Turning Point Therapeutics stock forecast , Turning Point Therapeutics (TPTX) stock cannot be a good investment choice. According to AI Pickup, the Turning Point Therapeutics stock price forecast for 2022 Aug. is $75.0499395818632

From Turning Point Therapeutics stock forecast , Turning Point Therapeutics (TPTX) stock cannot be a good investment choice. According to AI Pickup, the Turning Point Therapeutics stock price forecast for 2023 Jul. is $68.5986927017251

From Turning Point Therapeutics stock forecast , Turning Point Therapeutics (TPTX) stock cannot be a good investment choice. According to AI Pickup, the Turning Point Therapeutics stock price forecast for 2026 Jul. is $42.6182261768104

From Turning Point Therapeutics stock forecast , Turning Point Therapeutics (TPTX) stock cannot be a good investment choice. According to AI Pickup, the Turning Point Therapeutics stock price forecast for 2027 Jul. is $38.7997771409214

From Turning Point Therapeutics stock forecast , Turning Point Therapeutics (TPTX) stock cannot be a good investment choice. According to AI Pickup, the Turning Point Therapeutics stock price forecast for 2031 Jul. is $35.7602678921052

From Turning Point Therapeutics stock forecast , Turning Point Therapeutics (TPTX) stock cannot be a good investment choice. According to AI Pickup, the Turning Point Therapeutics stock price forecast for 2032 Jul. is $35.0778376091148

Is Turning Point Therapeutics stock overvalued?

Turning Point Therapeutics (TPTX) stock is expected to go DOWN . Therefore, AI Pickup would say that Turning Point Therapeutics (TPTX) stock is overvalued.

Will Turning Point Therapeutics stock price go up?

No. The Turning Point Therapeutics stock price forecast for 2023 Jul. is $68.5986927017251

Is Turning Point Therapeutics stock a good buy now?

Since closing price on 2022-07-06 is $75.1800003051758 and forecast for 2023 Jul. is $68.60, Turning Point Therapeutics stock is not a good 1 year investment.



14 Days Historical Data for Turning Point Therapeutics stock price

Date
Close
Open
Low
High
TPTX stock price for 2022-06-15
$74.90
$74.34
$74.34
$74.98
TPTX stock price for 2022-06-16
$74.49
$74.55
$74.26
$74.69
TPTX stock price for 2022-06-17
$74.46
$74.52
$74.03
$74.83
TPTX stock price for 2022-06-21
$74.58
$74.66
$74.55
$74.90
TPTX stock price for 2022-06-22
$75.30
$74.55
$74.48
$75.44
TPTX stock price for 2022-06-23
$75.15
$75.20
$74.86
$75.30
TPTX stock price for 2022-06-24
$75.17
$75.14
$75.01
$75.31
TPTX stock price for 2022-06-27
$75.27
$75.25
$75.10
$75.39
TPTX stock price for 2022-06-28
$75.06
$75.27
$75.06
$75.32
TPTX stock price for 2022-06-29
$75.30
$75.10
$75.08
$75.30
TPTX stock price for 2022-06-30
$75.25
$75.17
$75.15
$75.34
TPTX stock price for 2022-07-01
$75.11
$75.21
$74.93
$75.30
TPTX stock price for 2022-07-05
$75.15
$75.12
$74.87
$75.21
TPTX stock price for 2022-07-06
$75.18
$75.15
$74.95
$75.28


























































































































    • About
    • Company
    • Contact
    • Terms of Use
    • Privacy Policy
    • Risk Warning
    • Currency Map
    • COPYRIGHT © 2020 - 2021 by AI Pickup. All rights reserved.
    Risk Disclosure: Trading in any financial instruments including but not limited to stocks, ETF, bond, and forex and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount. Past results/performance of AI Pickup should not be any indication of any future results. You should make any investment after consulting your financial advisor and conducting your own research and due diligence. We exclude any and all liability for Our Content. Our Content shall not qualify as investment advice, counseling or any other information serving as a basis of investment (selling, purchasing, etc.) decisions.